Takeshita M, Suzuki K, Nakazawa M, Kamata H, Ishii M, Oyamada Y
Front Immunol. 2024; 15:1265792.
PMID: 38938569
PMC: 11208671.
DOI: 10.3389/fimmu.2024.1265792.
Thorlacius G, Bjork A, Wahren-Herlenius M
Nat Rev Rheumatol. 2023; 19(5):288-306.
PMID: 36914790
PMC: 10010657.
DOI: 10.1038/s41584-023-00932-6.
Mofors J, Bjork A, Richardsdotter Andersson E, Kvarnstrom M, Forsblad dElia H, Magnusson-Bucher S
RMD Open. 2020; 6(3).
PMID: 32994363
PMC: 7547543.
DOI: 10.1136/rmdopen-2020-001402.
Gkoutzourelas A, Liaskos C, Mytilinaiou M, Simopoulou T, Katsiari C, Tsirogianni A
Front Immunol. 2018; 9:2835.
PMID: 30581434
PMC: 6293197.
DOI: 10.3389/fimmu.2018.02835.
Sroka M, Bagavant H, Biswas I, Ballard A, Deshmukh U
Clin Exp Rheumatol. 2018; 36 Suppl 112(3):41-46.
PMID: 29465352
PMC: 6068008.
H1N1 vaccination in Sjögren's syndrome triggers polyclonal B cell activation and promotes autoantibody production.
Brauner S, Folkersen L, Kvarnstrom M, Meisgen S, Petersen S, Franzen-Malmros M
Ann Rheum Dis. 2017; 76(10):1755-1763.
PMID: 28760805
PMC: 5629946.
DOI: 10.1136/annrheumdis-2016-210509.
Sjögren's syndrome associated with systemic lupus erythematosus.
Tasdemir M, Hasan C, Agbas A, Kasapcopur O, Canpolat N, Sever L
Turk Pediatri Ars. 2016; 51(3):166-168.
PMID: 27738403
PMC: 5047367.
DOI: 10.5152/TurkPediatriArs.2016.2001.
Anti-Ro52 autoantibodies from patients with Sjögren's syndrome inhibit the Ro52 E3 ligase activity by blocking the E3/E2 interface.
Espinosa A, Hennig J, Ambrosi A, Anandapadmanaban M, Abelius M, Sheng Y
J Biol Chem. 2011; 286(42):36478-91.
PMID: 21862588
PMC: 3196112.
DOI: 10.1074/jbc.M111.241786.
Self protection from anti-viral responses--Ro52 promotes degradation of the transcription factor IRF7 downstream of the viral Toll-Like receptors.
Higgs R, Lazzari E, Wynne C, Gabhann J, Espinosa A, Wahren-Herlenius M
PLoS One. 2010; 5(7):e11776.
PMID: 20668674
PMC: 2909902.
DOI: 10.1371/journal.pone.0011776.
Extraordinary antigenicity of the human Ro52 autoantigen.
Burbelo P, Ching K, Han B, Bush E, Reeves W, Iadarola M
Am J Transl Res. 2010; 2(2):145-55.
PMID: 20407604
PMC: 2855627.
Rapid serological detection of autoantibodies associated with Sjögren's syndrome.
Burbelo P, Ching K, Issa A, Loftus C, Li Y, Satoh M
J Transl Med. 2009; 7:83.
PMID: 19778440
PMC: 2760511.
DOI: 10.1186/1479-5876-7-83.
Sensitive and robust luminescent profiling of anti-La and other autoantibodies in Sjogren's syndrome.
Burbelo P, Leahy H, Issa A, Groot S, Baraniuk J, Nikolov N
Autoimmunity. 2009; 42(6):515-24.
PMID: 19657778
PMC: 3417760.
DOI: 10.1080/08916930902911738.
The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3.
Higgs R, Gabhann J, Larbi N, Breen E, Fitzgerald K, Jefferies C
J Immunol. 2008; 181(3):1780-6.
PMID: 18641315
PMC: 2824853.
DOI: 10.4049/jimmunol.181.3.1780.
Sjögren's syndrome--study of autoantigens and autoantibodies.
Routsias J, Tzioufas A
Clin Rev Allergy Immunol. 2007; 32(3):238-51.
PMID: 17992591
DOI: 10.1007/s12016-007-8003-8.
Different temporal expression of immunodominant Ro60/60 kDa-SSA and La/SSB apotopes.
Reed J, Neufing P, Jackson M, Clancy R, Macardle P, Buyon J
Clin Exp Immunol. 2007; 148(1):153-60.
PMID: 17286801
PMC: 1868853.
DOI: 10.1111/j.1365-2249.2007.03331.x.
52-kDa Ro/SSA epitopes preferentially recognized by antibodies from mothers of children with neonatal lupus and congenital heart block.
Fritsch C, Hoebeke J, Dali H, Ricchiuti V, Isenberg D, Meyer O
Arthritis Res Ther. 2005; 8(1):R4.
PMID: 16356190
PMC: 1526571.
DOI: 10.1186/ar1848.
Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block.
Salomonsson S, Sonesson S, Ottosson L, Muhallab S, Olsson T, Sunnerhagen M
J Exp Med. 2005; 201(1):11-7.
PMID: 15630133
PMC: 2212767.
DOI: 10.1084/jem.20041859.
The 52 000 MW Ro/SS-A autoantigen in Sjögren's syndrome/systemic lupus erythematosus (Ro52) is an interferon-gamma inducible tripartite motif protein associated with membrane proximal structures.
Rhodes D, Ihrke G, Reinicke A, Malcherek G, Towey M, Isenberg D
Immunology. 2002; 106(2):246-56.
PMID: 12047754
PMC: 1782712.
DOI: 10.1046/j.1365-2567.2002.01417.x.
Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study.
Tzioufas A, Wassmuth R, Dafni U, Guialis A, Haga H, Isenberg D
Ann Rheum Dis. 2002; 61(5):398-404.
PMID: 11959762
PMC: 1754090.
DOI: 10.1136/ard.61.5.398.